The acquisition of cell motility is an early step in melanoma metastasis. Here we use intravital imaging of signalling reporter cell-lines combined with genome-wide transcriptional analysis to define signalling pathways and genes associated with melanoma metastasis. Intravital imaging revealed heterogeneous cell behaviour in vivo: o10% of cells were motile and both singly moving cells and streams of cells were observed. Motile melanoma cells had increased Notch-and SRF-dependent transcription. Subsequent genome-wide analysis identified an overlapping set of genes associated with high Notch and SRF activity. We identified EZH2, a histone methyltransferase in the Polycomb repressive complex 2, as a regulator of these genes. Heterogeneity of EZH2 levels is observed in melanoma models, and co-ordinated upregulation of genes positively regulated by EZH2 is associated with melanoma metastasis. EZH2 was also identified as regulating the amelanotic phenotype of motile cells in vivo by suppressing expression of the P-glycoprotein Oca2. Analysis of patient samples confirmed an inverse relationship between EZH2 levels and pigment. EZH2 targeting with siRNA and chemical inhibition reduced invasion in mouse and human melanoma cell lines. The EZH2-regulated genes KIF2C and KIF22 are required for melanoma cell invasion and important for lung colonization. We propose that heterogeneity in EZH2 levels leads to heterogeneous expression of a cohort of genes associated with motile behaviour including KIF2C and KIF22. EZH2-dependent increased expression of these genes promotes melanoma cell motility and early steps in metastasis.
INTRODUCTION
Melanoma is a skin cancer arising from the uncontrolled proliferation and invasion of melanocytes. Melanoma metastasis starts with the acquisition of motility in the primary tumour. Previous intravital imaging of B16 melanoma showed that motile cells had lower pigment levels and higher Brn2 promoter activity compared with non-motile cells, 1 indicating that motile cells may represent a less differentiated subset of cells. This is consistent with studies suggesting that melanoma cells revert to a 'neural crest-like' state during metastasis. 2, 3 It has also been proposed that melanoma cells switch between mutually exclusive invasive and proliferative states. 4, 5 The proliferative state is characterized by high expression of the melanocyte transcription factor MITF and low Brn2 expression, whereas the invasive state is characterized as having Brn2 expression but low MITF expression. 6, 7 However, little is known about the signalling pathways that might drive the changes in differentiation and promote a motile state.
We chose to use intravital imaging of transcriptional reporters to monitor signalling of B16 melanoma cells during the early steps of the metastatic process. We focussed on two pathways thought to be important in melanoma metastasis, the Notch and SRF pathways. Notch signalling is usually activated through membrane-bound ligand-receptor interactions leading to Notch receptor activation, cleavage and the release of the active Notch intracellular domain (NICD). NICD binds to the DNA-binding factor RBPSUK (RBPjκ) and leads to the increased transcription of target genes. 8 Melanoma cells with constitutively active Notch signalling show increased motility in vitro and increased lung colonization, through Notch-mediated regulation of N-cadherin. [9] [10] [11] Furthermore, the Notch pathway has an important role in maintaining melanocyte stem cells, 12 and Notch activation in mature melanocytes is sufficient to induce re-programming and de-differentiation to neural crest stem cell-like cells. 13 The SRF pathway links changes in the actin cytoskeleton to gene transcription. Actin polymerization leads to a decrease in the myocardin-related transcription factor MRTF-A binding to G-actin. MRTF-A (also called MKL) is a co-activator of SRF and subsequently accumulates in the nucleus leading to increased SRF-dependent transcription. 14 Loss of MRTF-A in B16 melanoma cells leads to decreased experimental lung metastasis. 15 Depletion of the SRF targets MLC2 and NMHCIIa also reduced invasion and metastasis. Another actomyosin regulator, RhoC, is upregulated in metastatic melanoma cells 16 and can increase SRF signalling. 17 Although both SRF and Notch are implicated in metastasis, it is not clear whether their activity is simply permissive for metastasis or whether they are dynamically regulated during different stages of the metastatic process.
In addition to transcription factor activity, the expression of many genes is influenced by post-translational modification of histones. EZH2 is part of the Polycomb repressive complex 2 (PRC2) and catalyses the tri-methylation of histoneH3 at lysine 27 (H3K27me3), a mark usually associated with gene repression. 18 During development EZH2 silences differentiation-associated genes to maintain cells in a progenitor state. 19 EZH2 is upregulated in many tumour types including melanoma and increases in expression from benign nevi to metastatic melanoma. 20, 21 Further EZH2 expression levels are coupled to B-Raf, a common melanoma oncogene. 22 EZH2 has also been implicated in cancer cell EMT and invasion. 20, 21, 23 In this study, we use intravital imaging to show heterogeneous transcriptional activation of the Notch and SRF pathways in melanoma cells in vivo and activation of these pathways in motile cells. Genome-wide analysis reveals that MRTF/SRF targets and genes upregulated in the Notch reporter high population show significant overlap. Further, these overlapping genes are regulated by EZH2. We demonstrate key roles for EZH2 in suppressing pigment production in invasive melanoma cells by repressing Oca2 levels. Further, we show that EZH2 enables invasion and metastasis by positively controlling the expression of KIF2C and KIF22.
RESULTS

B16 melanoma shows heterogeneous motile behaviour in vivo
Intravital studies of cancer motility have revealed heterogeneous cancer cell behaviour. 1, 24, 25 We examined the behaviour of metastatic melanoma cells using intravital imaging of B16 F2 tumours followed by cell tracking. The majority of B16 F2 melanoma cells were non-motile. On average 6.6% of cells were motile, with a range of 0-22% per field of view. (Figure 1ai ,ii and Supplementary Movie 1). Motile melanoma cells showed speeds between 0.4 to 6.7 μm/min. Further, the distribution of directions was significantly non-uniform, with melanoma cells predominantly moving towards the tumour margin ( Figure 1aiii ). Cell tracking also revealed that some melanoma cells moved as single cells, whereas other cells followed the same path (Figure 1b and Supplementary Movie 2). Cells with tracks that overlapped in a 15-min time window (see methods for a more detailed classification) moved significantly faster than cells moving in isolation; however, there was no significant difference in persistence ( Figure 1c ). We propose that cells following the same paths are using multicellular streaming 26 as a mode of motility, whereas cells in isolation are using single-cell amoeboid motility. Quantification of motile cells showed that, on average, 44% of motile cells exhibited multicellular streaming and 56% display single-cell motility (Figure 1d ).
Generation of Notch and SRF reporter B16 F2 lines
Heterogeneity in signalling within the tumour could account for the different behaviours of non-motile and motile cells. We hypothesized that two signalling pathways implicated in melanoma metastasis, SRF and Notch, might be differentially activated in migratory and non-migratory cells. To test this we generated B16 F2 reporter cell lines to visualize the signalling status of Notch (using CBFRE::GFP reporter) and SRF signalling (using 3DA::2eGFP reporter -see Supplementary Figure 1 for more details of reporter constructs). Stable monoclonal reporter cell lines were made in B16 F2 cells containing a constitutive mRFP membrane label (Supplementary Figure 1) to aid visualization. To ensure that any heterogeneity in signalling observed was not the result of heterogeneity within the starting B16 F2 cell line, multiple SRF reporter clones were chosen, 1 3DA::2eGFP and 1 3DA::2eGFP Fos3′UTR reporter clone (Fos 3′UTR helps destabilize eGFP mRNA), but only one responsive Notch CBFRE::GFP reporter clone was generated. The veracity of the Notch reporter was confirmed by transfection of NICD together with mCherry to label transfected cells. NICD transfection increased the expression of eGFP, whereas empty vector alone had no effect ( Figure 2ai ). The 3DA::2eGFP SRF reporter cell line did not show changes in eGFP expression following NICD transfection. In contrast, 5 μM Cytochalasin D, which activates the SRF co-factor MRTF/MAL, increased eGFP expression in nearly all of the 3DA::2eGFP SRF reporter cells ( Figure 2aii ). Therefore, the reporter cell lines were responsive to the relevant signal in vitro (Figure 2a ).
Notch and SRF transcriptional activity is heterogeneous in B16 cells in vivo
We next imaged the B16 reporter cell lines in vivo. To obtain more general information about the tissue structure, we imaged collagen second harmonic signal and used C57/BL6 mice with GFP-CAAXlabelled endothelial cells. 27 Notch reporter tumours showed heterogeneity in Notch signalling with few GFP positive, Notch active cells (Figure 2bi ,ii and Supplementary Figure 1C ). However, we did note an exclusive relationship between CBFRE::GFP positive cells and the presence of melanin pigment within cells measured using near infrared stimulation of visible emission (Figure 2aiii ). 1 The B16 F2 3DA::2eGFP SRF (and 3DA::2eGFP Fos3′UTR) reporter tumours also showed that SRF transcriptional activity was heterogeneous in vivo ( Figure 2ci ,ii and Supplementary Figure 1C ). 3DA::2eGFP positive cells were scattered throughout the tumour, both in small clusters and individual positive cells. Similar to the Notch reporter, we observed that SRF reporter positive cells displayed an exclusive relationship with pigment ( Figure 2ciii and Supplementary Figure 2A ). Cells with high SRF-dependent transcriptional activity had low pigment levels and vice versa. This suggests an overlap between the motile low pigment cells reported in Pinner et al. 1 and cells with both active SRF signalling and Notch signalling.
Motile behaviour of B16 cells in vivo is associated with increased Notch and SRF transcriptional activity Given the heterogeneity in Notch and SRF signalling and their links to melanoma metastasis, we hypothesized that the cells with active Notch and SRF signalling were more motile. Quantification of Notch reporter tumours showed that motile cells had increased Notchdependent transcription compared with non-motile cells (Figure 2di and Supplementary Movie 3). Similarly, motile cells had increased SRF reporter activity compared with non-motile cells (Figure 2dii , Supplementary Movie 4 and Supplementary Figure 2A ). This indicates that active Notch and SRF signalling is associated with cell motility in melanoma. However, both Notch and SRF reporter activity was occasionally observed in non-motile cells, suggesting that each pathway alone was not sufficient for motility.
We next investigated subsequent steps in the metastatic process. Metastatic cells in the lymph node of Notch reporter tumours showed little GFP intensity, similar to non-motile cells in the primary tumour, indicating a lack of Notch signalling ( Figure 2di and Supplementary Figure 2B ). In contrast, 3DA::2eGFP SRF reporter cells in the lymph node were GFP positive, similar to motile cells in the primary tumour, suggesting that SRF signalling remained active in cells that arrived at the metastatic site ( Figure 2dii and Supplementary Figure 2C ). Together these data suggest a transient activation of Notch signalling during melanoma metastasis, but a more prolonged activation of SRF signalling.
The data above show that both Notch and SRF signalling are increased in invasive melanoma cells. This observation predicts that 'double-positive' cells with high levels of both signalling pathways should be observed. We tested this hypothesis by staining CBFRE::GFP Notch reporter tumours for the SRF cofactor MRTF/MKL ( Figure 2ei ). Activation of SRF signalling is associated with nuclear translocation of MRTF/MKL; therefore, the activity of SRF can be inferred from the localization of MRTF/MKL. Quantification revealed that cells with both active Notch and SRF signalling formed 5% of the tumour (Figure 2eii ); this number corresponds well with the overall proportion of motile cells in the tumour (6.6% as shown in Figure 1aii ). Further, Fisher's exact statistical test revealed a significantly greater fraction of doublepositive cells than would be expected if SRF and Notch signalling were independently regulated (P = 0.0023).
Notch and SRF signalling are associated with a common transcriptional programme Given that SRF and Notch signalling were increased in motile cell populations, we sought to identify any genes associated with both elevated Notch and SRF signalling, and whether these genes (Supplementary File 3). Gene Set Enrichment Analysis (GSEA, Broad Institute) showed significant overlap (P-value o 0.001) between MRTF/MKL target genes and genes upregulated in the Notch reporter high population ( Figure 3a ). Out of 145 MRTF target genes and 75 genes upregulated in the Notch high population, 29 showed overlap between the two populations. These genes will be referred to as 'invasive cell population high' genes ( Figure 3b , Table 1 ). Interestingly, many of these 29 genes were not upregulated when Notch signalling was ectopically activated using NICD overexpression ( Supplementary Figure 3Ai ). This suggests that Notch signalling might be coincidently activated with the 'invasive cell population high' genes, but not directly activating them. As a control, we confirmed that CBFRE:: GFP Notch high genes did show significant overlap with NICD Notch target genes ( Supplementary Figure 3Aii ). We therefore propose that the 'invasive cell population high' genes are not necessarily Notch target genes, but that a critical regulator of invasive potential promotes both Notch and SRF pathway activity.
To gain further evidence that the 'invasive cell population high' genes were associated with migratory cells in vivo, we investigated their expression in melanoma cells with high Brn2 activity. The activity of a Brn2::GFP reporter is elevated in migratory melanoma cells in vivo, 1 and both MRTF target genes and CBFRE::GFP high genes are enriched in cells with high Brn2 promoter activity (Supplementary Figure 3B ). Further the 'invasive cell population high' genes were also enriched in cells with high Brn2 promoter activity (Supplementary Figure 3C) . These data strengthen the link between 'invasive cell population high' genes and motile melanoma cells.
EZH2 regulates the transcriptional programme common to cells with high Notch and SRF activity
We next explored what factors may regulate the 'invasive cell population high' genes as we hypothesized that a critical regulator of invasive potential promotes expression of these genes. The Molecular Signatures Database (MSigDB, Broad Institute) was used to search for published gene sets with the most overlaps with the 'invasive cell population high' genes (Supplementary File 1). Interestingly, genes positively regulated by EZH2 in prostate cancer cells (identified by Nuytten et al. 28 ) showed significant overlap (FDR = 1.22 × 10 − 14 ) with 'invasive cell population high' genes (Supplementary File 1). Consistent with reports linking RhoA to SRF activity and invasion, RhoA-regulated genes also showed significant overlap with 'invasive cell population high' genes (Supplementary File 1). We decided to pursue the role of EZH2 in melanoma motility due to its global role in gene transcription regulation and previous reports of a functional role in cancer metastasis. 23, 29 Microarray analysis of cells transfected with two independent EZH2 siRNA identified genes positively regulated by EZH2 in B16 cells (knockdown efficiency shown in Figure 3c and genes listed in Supplementary File 1). EZH2 depletion did not affect cell viability nor induced senescence (Supplementary Figure  3D ). GO analysis showed that genes positively regulated by EZH2 were enriched for cytoskeletal components (Supplementary File 1). We confirmed that EZH2 positively regulates the expression of multiple kinesins and other genes identified in the microarray analysis using QRT-PCR analysis (Figure 3di ). Analysis of TGCA data revealed strong positive correlations between EZH2 mRNA and KIF2C, KIF22 and TOP2A mRNA ( Figure 3dii ). Finally, GSEA confirmed a significant overlap of genes positively regulated by EZH2 in B16 cells with the 'invasive cell population high' genes ( Figure 3e ). These analyses confirm EZH2 as a positive regulator of the 'invasive cell population high' genes.
The data above show that EZH2 positively regulates the 'invasive cell population high' genes, including multiple kinesins. Although EZH2 is predominantly thought of as a repressor of transcription, it can positively regulate genes (Figure 3d ). 18, 30 We hypothesize that EZH2 levels may control activity through the Notch and SRF pathways. In support of this idea, EZH2 depletion reduced Notch and SRF luciferase reporter activity (Figure 3f ). EZH2 depletion also reduced SRF transcript levels (Figure 3g ), this confirms EZH2 regulates the SRF pathway.
EZH2 levels are heterogeneous in mouse and human melanoma Intravital imaging showed that cell behaviour is heterogeneous in vivo with~6% of cells being motile. If EZH2 regulates the expression of genes upregulated in motile cells, then EZH2 levels should be heterogeneous in vivo. Immunohistochemistry of two different mouse melanoma models, including the B16 model, revealed heterogeneity in EZH2 levels in vivo ( Supplementary  Figure 4Ai ). In both models, the invasive tumour margin had higher levels of EZH2 ( Supplementary Figure 4Aii ). The distribution of EZH2 levels in sections of human melanoma metastases was similar to that found in the mouse models (Supplementary Figure 4E ). Immunofluorescence staining also revealed that the heterogeneity in EZH2 levels correlated with variations in H3K27Me3 levels ( Supplementary Figures 4B and C) . Depletion of EZH2 in B16 cells significantly decreased H3K27me3 levels (Supplementary Figure  4D) . These data establish that intra-tumour heterogeneity in EZH2 expression is a feature of melanoma and correlates with changes in K27Me3 modification of its substrate Histone H3.
We next investigated variation of EZH2 expression in a panel of 27 human melanomas. This revealed both inter-and intra-tumour heterogeneity in the levels of EZH2. We also observed that melanoma with the highest levels of EZH2 had the lowest levels of pigmentation (Figures 4a and b ). This negative correlative was interesting because we had previously found that the invasive subpopulation of melanoma cells in the B16 model lacks pigment. Even within the same tumour, highly pigmented cells had lower levels of EZH2 expression than their neighbours (Figure 4c ). These data demonstrate inverse relationship between EZH2 and pigmentation in human melanoma. 
EZH2 regulates pigment levels through Oca2
The negative correlation in human tumours between EZH2 levels and pigmentation and previous work showing invasive cells have lower pigment 1 prompted a functional analysis of EZH2 on pigment levels. Depletion of EZH2 resulted in a two-to fourfold increase in pigment as determined by cell pellets and two-photon microscopy (Figure 5a ). Depletion of another PRC2 component, Suz12, also increased pigment levels (Supplementary Figure 5A ), suggesting that EZH2 may regulate pigment levels via PRC2mediated gene repression. We tested the importance of EZH2 catalytic function by using DZNep, which inhibits EZH2 methyl transferase functions. 31 Treatment of both B16 and human 501mel cells with DZNep for 48 h led to a marked increase in melanosomes ( Figure 5b ). We did not observe any consistent changes in mRNA of the pigmentation genes Slc45a2, Tyr, Tyrp1 or Dct following EZH2 depletion (Supplementary Figure 6A ). However, both siRNA depletion and pharmacological targeting of EZH2 caused an increase Oca2 mRNA (Figure 5c ). Further, Oca2 and EZH2 are expressed in a mutually exclusive manner across a large number of melanoma samples: tumours with high levels of EZH2 have low Oca2 mRNA and vice versa (Supplementary Figure 6B) .
Oca2 encodes the P-protein, a transmembrane protein localized to melanosomes 32, 33 and loss of function mutation leads to a form of albinism. 34 Depletion of Oca2 with two independent siRNA markedly decreased pigment levels in B16 cells (Figure 5d -cell viability was unaffected Supplementary Figure 6C ). The effect of EZH2 on pigment levels was ablated on combined knockdown of EZH2 and Oca2 (Figure 5e ), suggesting that EZH2 affects pigment levels through regulation of the Oca2 gene. Further, pigment production in B16 cells was highly sensitive to the levels of Oca2, as 50% depletion of Oca2 mRNA using a low concentration of siRNA was sufficient to prevent the increase in melanosomes following inhibition of EZH2 (Figure 5f ).
EZH2 regulates melanoma invasion and metastasis
Given that EZH2 can regulate the genes associated with motile behaviour in a mouse model of melanoma, we explored possible links between EZH2 and metastasis in human melanoma. Analysis of microarray data 35 comparing A375P (non-metastatic) and A375M2 (metastatic) melanoma cells showed that genes positively regulated by EZH2 are upregulated in the A375M2 metastatic subline compared with the A375P parental population (Figure 6ai ). More strikingly, genes upregulated in human melanoma patients who developed metastasis within 4 years, compared with patients who did not, showed significant overlap with genes positively regulated by EZH2 in B16 melanoma (Figure 6aii ). These data are consistent with a role for EZH2 in regulating human melanoma metastasis. We next investigated the functional role of EZH2 in melanoma motility and metastasis. Depletion of EZH2 led to changes in actin cytoskeleton regulation (Figure 6b ). EZH2 depleted cells had an increase in cell area (Figure 6bii ) and a decrease in phosphorylation of the plasma membrane-cortex linker proteins, ERM (Figure 6biii ). We also observed a similar change in cell morphology on depletion of Suz12 ( Supplementary Figure 5B ), suggesting a more general PRC2 regulation of the cytoskeleton. EZH2 depletion decreased invasive protrusions into collagen-matrigel matrices and subsequently decreased invasion in both B16 and 5555 mouse melanoma cell-lines (Figure 6c ). DZNep inhibition of EZH2 catalytic function also reduced invasion of B16 and 5555 cells. Importantly, we confirmed this finding in two human melanoma cell lines (501mel and CHL-1, Figures 6d and e ). Many regulators of cell migration and invasion are also required for extravasation and lung colonization during metastasis. EZH2depleted cells were significantly under-represented in the lungs 48 h after co-injection intravenously with control cells (Figure 6f) . These data establish that EZH2 is required for efficient lung colonization by metastatic melanoma.
We next tested whether any of the 'invasive cell population high' genes might be involved in EZH2-mediated melanoma invasion and metastasis. We focused on two cytoskeletal genes whose expression is regulated by EZH2 (additionally confirmed using DZNep-Supplementary Figure 7A ) and correlates with EZH2 mRNA levels across a large cohort of melanoma patients (Figure 3dii ). Depletion of the kinesins KIF2C and KIF22 significantly reduced invasion into collagen-matrigel matrices in both B16 and 5555 mouse melanoma cell lines (Figure 7a and b) . Neither kinesin was required for cell viability (Supplementary Figure 7B ). In contrast, depletion of the KIF11, which is not EZH2 regulated (Figure 3di ), had no effect. Further, KIF22 depletion also led to an increase in the area of B16 cells (Figure 7c ). Consistent with the identification of KIF2C and KIF22 as MRTF/SRF-regulated genes, siRNA-mediated depletion of SRF reduced the invasion of melanoma cells (Supplementary Figure 8B) . Depletion of both KIF2C and KIF22 significantly reduced lung colonisation in a shortterm metastasis assay (Figure 7d ). Therefore, we propose that EZH2 regulation of KIF2C and KIF22 promotes the invasive phenotype of mouse melanoma cells.
DISCUSSION
Relatively little is known about the initial steps of melanoma metastasis in vivo. We show that even in an aggressive mouse melanoma cell line, 6-7% of cells are motile in vivo. This is similar to murine breast cancer models. 24 Most motile cells use an amoeboid-like single-cell mode of motility; however,~40% exhibit a streaming mode of motility whereby motile cells share the same tracks. Both the splitting and merging of groups of cells moving along common tracks was observed. This suggests that multicellular streaming is not associated with stable cell-cell junctions that persist for long periods (415 min). Streaming cells are also faster than singly motile cells and may be following pregenerated tracks in the ECM, potentially made by fibroblasts, as seen in vitro. 36 We show that Notch-and SRF-dependent transcriptional activation is heterogeneous in vivo and increased in motile cells. More detailed analysis reveals that SRF signalling is increased in both singly moving and streaming cells (Supplementary Figure 2B ). Notch signalling is clearly elevated in singly moving cells, but the data are more ambiguous in streaming cells (Supplementary Figure 2B) . This may reflect the lower range of Notch reporter cells or some mechanistic difference between singly moving and streaming cells. The cell lines are clonal in origin; therefore, heterogeneity in SRF and Notch activity is unlikely to result from genetic differences. SRF signalling is responsive to both soluble factors, such as LPA and SDF-1, and external physical tension. 37 Notch signalling can be activated through cell-cell interactions and hypoxia. 38, 39 Thus, many cell extrinsic factors can modulate SRF and Notch signalling potentially leading to signalling heterogeneity. Further, we now demonstrate that EZH2 function influences activity of SRF and Notch reporters.
Increased Notch-and SRF-dependent transcriptional activation in motile melanoma cell population is consistent with previous work showing the importance of these pathways for melanoma Notch reporter high  population  CCNB1  MCM3  TOP2A  SH3BGRL  KIF22  PLK1  KIF11  AXL  AURKA  BUB1  CDCA5  PRKG2  KIF2C  BIRC5  KIF23  CASP7  CCNF  SPAG5  MSN  CCK  MXD3  PBK  CDCA8  CDC20  EPB4.1L2  BICD1  PAK3 CSPRS DUT metastasis. 9, 15 However, we noted that activation of SRF was not sufficient to drive cell invasion when EZH2 function was blocked ( Supplementary Figure 8C) , indicating that there are likely to be additional mechanisms by which EZH2 controls invasive potential. Although Notch activity is associated with melanoma metastasis, it does not appear to be directly involved in the regulation of cell migration. Depletion of RBPjK had no effect on invasion (Supplementary Figure 8B) , and NICD overexpressing cells did not show elevated motility in vivo (data not shown). Notch signalling may promote metastasis by mechanisms unrelated to cell migration.
Combining the transcriptional reporters with genome-wide analysis enabled identification of genes associated with melanoma cell motility. Many of these 'invasive cell population high' genes were associated with the cell cycle and the microtubule cytoskeleton. Our observations are similar to previous reports in breast cancer where more than half of the differentially regulated genes in the motile cell population in vivo were associated with the cell cycle, and further the Polycomb proteins EZH1 and EED were also upregulated. 40 Multiple kinesins were upregulated in the motile population of both B16 melanoma and breast cancer 40 such as KIF2C and KIF23. Thus, the 'invasive cell population high' genes are likely to be relevant in many tumour types. We show that EZH2 can positively regulate the expression of KIF2C and KIF22. How EZH2 positively regulates these genes is unknown as EZH2 and PRC2 are classically considered to silence gene expression. 18 EZH2 may indirectly regulate these genes through silencing a transcriptional repressor, or it may directly methylate and activate proteins that positively regulate SRF and Notch signalling. EZH2 has a modest effect on the basal activity of SRF and Notch reporter constructs ( Figure 3 ) and may make melanoma cells more responsive to cues that activate SRF and Notch signalling. The heterogeneity in EZH2 levels in both human and mouse melanoma is consistent with a role for EZH2 in regulating the switch to the relatively rare motile state. The epigenetic mechanism of action of EZH2 could imply that melanoma cells would remain in this more motile state for a prolonged period.
Previous work has shown that the motile cells in B16 melanoma are less pigmented than non-motile cells. 1 We show that EZH2 can control this phenotype change associated with motility, through regulation of Oca2/P-protein expression. We hypothesize that this is via direct PRC2-dependent regulation of the Oca2 locus as high H3K27me3 levels could be detected in multiple lymphoma cell lines that do not express Oca2. 31 Depletion of EZH2 leads to changes in the actin cytoskeleton and a reduction in invasion and metastasis of melanoma cells. We identified two kinesins, KIF2C and KIF22, as having a role in EZH2-dependent melanoma invasion. Previous reports show that KIF2C is associated with motility and metastasis in multiple cancer types. 41, 42 Taken together, these data place EZH2 as a central regulator of both the amelanotic and migratory phenotype of a subset of melanoma cells associated with metastasis. In conclusion, we propose that heterogeneity in EZH2 levels leads to heterogeneous expression of a cohort of genes associated with motile behaviour in vivo. These genes include many kinesins, and a subset is regulated by SRF. Elevated expression of these genes is important for melanoma cells to respond to pro-migratory cues in the primary tumour micro-environment and favours their extravasation into the lung parenchyma. 
MATERIALS AND METHODS
Mice and imaging
Tumour imaging was performed as described previously. 43 Mice were injected subcutaneously on the flank with 1 × 10 6 melanoma cells. On the day of imaging, mice were anaesthetized and tumour exposed as described previously. 43 All images acquired with LSM780 (Carl Zeiss, Cambridge, UK). VE-Cadherin:GFPCAAX 27 and C57BL6 mice used for intravital imaging. C57BL6 mice used for lymph node end point studies. Two-photon Ti-Sapphire laser (Coherent, Ely, UK) used to image pigment both in vitro and in vivo with pigment emission between 500 and 550 nm.
Image analysis and quantification
Quantification of confocal images of melanoma cell motility, reporter and pigment intensity in LSM Zen 2009 (Carl Zeiss) and pigment/EZH2 intensity in human tissue array performed in ImageJ. Cellular pigment or reporter intensity was corrected for background levels and then normalized to the average intensity for the whole image. Cell area measured in Volocity (Perkin Elmer, Beaconsfield, UK). Cell tracking was performed with ImageJ Manual Tracking Plug-in. Overlapping tracks of motile cells were defined as parallel tracks within 5 μm of each other laterally, with overlap of longer than 12 μm and cells present within 15 min of each other. Persistence was calculated by actual distance travelled by the cell divided by the Euclidean distance.
Invasion assays
Cells were plated on collagen/matrigel matrices (~4.6 mg/ml collagen I (BD, Oxford, UK) and 2.2 mg/ml matrigel (BD)) and left to invade down in to the gel for 48 h. The number of cells invaded into the gel was normalized to non-invading cells.
Lung colonization assays
A total of 1 × 10 6 B16 F10 cells containing 50:50 mix of mCherry, and GFP cells transfected with control or EZH2 targeted siRNA were injected into mouse tail-vein. After 48 h mice were killed, lungs dissected and imaged using × 10 lens (Carl Zeiss). Images were analysed for area of mCherry vs GFP cells using Volocity (Perkin Elmer). The ratio of control transfected B16 F10 to EZH2 siRNA transfected B16 F10 cells was normalized to the ratio of mCherry:GFP cells injected and from control mice.
Microarray, GSEA and TCGA analysis Microarray analysis was performed together with The Genome Centre at The Barts London using REF6V3 Illumina chips (Illumina, Little Chesterford, UK). Fold changes were calculated as average for replicates. Three replicates of CBFRE::GFP Notch reporter high versus low, two replicates of Brn2::GFP reporter high versus low and two replicates of B16 control and EZH2 siRNA treatment were performed. GSEA was performed using free software from The Broad Institute of MIT following the program guidelines. The 'MRTF targets' gene set was defined as genes downregulated by 41.5-fold in B16 F2 cells on MRTF depletion performed in Medjkane et al. 15 The 'invasive cell population high' genes were defined as genes both downregulated 41.5fold on MRTF depletion and upregulated 41.2-fold in the CBFRE::GFP High population. TCGA data were used from cBioportal website.
